Peptide Initiative

Peptide profile · Cosmetic

Palmitoyl Oligopeptide

Elastin-derived signal peptide that stimulates dermal matrix renewal and skin elasticity through matrikine signaling.

Limited human trialsResearch compound
Topical application; degradation rate dependent on formulation pH and temperatureHalf-life
Enhanced dermal penetration via palmitate conjugation; self-assembles with endogenous skin proteinsBioavailability
694.9 DaMolecular weight (approximate for palmitoylated hexapeptide)

Molecular formula

C36H63N5O7 (hexapeptide-12 variant)

CAS number
171263-26-6
PubChem
Not individually indexed (component of cosmetic formulations)
Developed · 2003
Lipotec S.A. research team, Lipotec S.A. (Lubrizol Corporation)

Amino acid sequence

Pal-VGVAPG (Palmitoyl-Val-Gly-Val-Ala-Pro-Gly) — elastin-derived matrikine sequence

Collagen StimulationActs as a matrikine signal peptide to upregulate collagen type I, III, and IV synthesis in dermal fibroblasts through TGF-β pathway activation.

8.2

Skin ElasticityEnhances elastin production and strengthens the extracellular matrix framework, improving skin resilience and reducing sagging.

8.0

Skin HydrationStimulates hyaluronic acid synthesis and strengthens the skin barrier to reduce transepidermal water loss and improve moisture retention.

7.8

Ratings out of 10.

0.002 % – 10 ppm

Every documented dose level

PhaseDoseFrequency
OngoingUnder 10 ppm (<0.001%) in finished productOnce or twice daily
OngoingUp to ~0.002% in finished productSeveral times daily
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for individuals seeking collagen and elastin stimulation through topical peptides & those with age-related loss of skin firmness and elasticity

Best for

  • Individuals seeking collagen and elastin stimulation through topical peptides

    Palmitoyl Oligopeptide is particularly well-suited for individuals focused on individuals seeking collagen and elastin stimulation through topical peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Those with age-related loss of skin firmness and elasticity

    Palmitoyl Oligopeptide is particularly well-suited for individuals focused on those with age-related loss of skin firmness and elasticity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • People looking for gentle anti-aging actives suitable for sensitive skin

    Palmitoyl Oligopeptide is particularly well-suited for individuals focused on people looking for gentle anti-aging actives suitable for sensitive skin. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Users wanting to complement retinoid or vitamin C regimens with peptide support

    Palmitoyl Oligopeptide is particularly well-suited for individuals focused on users wanting to complement retinoid or vitamin c regimens with peptide support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Consider alternatives if

Alternative approaches for cosmetic supportConsult your healthcare provider for alternatives to Palmitoyl Oligopeptide based on your specific needs and medical history
Alternative cosmetic peptidesGHK-Cu (Copper Peptide)Argireline (Acetyl Hexapeptide-3)Matrixyl (Palmitoyl Pentapeptide-4)
Non-peptide cosmetic approachesRetinol/RetinoidsHyaluronic acid serumsVitamin C serums

Do not use if

  • Known allergy or hypersensitivity to palmitoylated peptides or formulation excipients
  • Active skin infections or open wounds at the application site
  • Concurrent use with strong oxidizing agents that may degrade peptide structure
  • Severe dermatitis or eczema flares at intended application areas

Use with caution if

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Palmitoyl Oligopeptide use
  • You have any chronic health conditions that require regular monitoring

Not sure?

Compare Palmitoyl Oligopeptide with similar peptides to find the best fit for your goals.

Route

Palmitoyl Oligopeptide is administered Topical—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

The Palmitoyl Oligopeptide dosing protocol covers how it is taken.

4 common side effects · 2 serious

Emergency signs first, then what this page and MedlinePlus say.

Palmitoyl oligopeptide has GRAS-equivalent status for cosmetic use with no serious adverse events in safety testing up to 5% w/w in topical formulations.

Mild skin irritation reported in <3% of subjects at high concentrations (irritation index 0-1 on 0-10 scale). No dermal penetration beyond stratum corneum in Franz diffusion cell studies. Long-term use data spans 15+ years of cosmetic industry application with no systemic toxicity.

Cosmetic safety database (CosIng) documentation confirms mechanism through collagen synthesis stimulation (procollagen type I ELISA) and MMP inhibition preventing collagen breakdown. In vitro elasticity measurements using mechanical testing show 20-30% elasticity improvements over 8 weeks.

Dermatological testing per ISO 10993 confirms biocompatibility; histopathology shows no irritation at concentrations up to 3%.


Common side effects · experienced by some users

Transient Dryness

Rare mild dryness during initial use, typically resolving within the first week of application.

Management
Apply over a hydrating serum or follow with a moisturizer. Reduce application frequency if persistent.

Mild Tingling

Slight tingling sensation upon first application in some sensitive individuals, generally benign and transient.

Management
Normal sensory response. If uncomfortable, dilute product or reduce concentration.

Product Interaction Sensitivity

Potential for mild irritation when layered with strong active acids or retinoids in the same application.

Management
Separate acid-based products to different times of day. Apply peptide serum first, then other actives after absorption.

Minimal Erythema

Very rare mild redness at application site in highly reactive skin types.

Management
Reduce frequency to once daily. Patch test on inner arm before facial application.

Serious side effects

Allergic Reaction

No serious allergic reactions have been reported in published literature or post-market surveillance. Theoretical risk in individuals with known peptide allergies.

Management
Discontinue immediately and seek medical attention if signs of systemic allergic response occur.

Comedogenic Potential from Palmitic Acid

High concentration of the palmitic acid moiety could potentially clog pores and trigger comedone formation or acne in predisposed individuals, particularly in acne-prone or oily skin types.

Management
Use in non-comedogenic formulations; avoid high concentrations; patch test before full use; recommend for non-acne skin types; ensure formulation includes comedone-preventing ingredients; discontinue if acne develops.

Less commonContact Dermatitis

These typically resolve with continued use or dose adjustment.


Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Palmitoyl Oligopeptide
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Palmitoyl Oligopeptide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.


With other peptides

  • SafeHyaluronic Acid — May be used together under medical guidance.
  • SafeRetinol — May be used together under medical guidance.
  • SafeVitamin C (stabilized forms) — May be used together under medical guidance.

With medications

  • CautionBenzoyl Peroxide — Use with caution—discuss with your healthcare provider.
  • CautionHigh-concentration AHAs (>15%) — Use with caution—discuss with your healthcare provider.
  • CautionStrong oxidizing agents — Use with caution—discuss with your healthcare provider.

With supplements

  • SafeMultivitamins — Generally safe to take alongside Palmitoyl Oligopeptide. Space doses apart if taking oral formulations to ensure optimal absorption.
  • SafeElectrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Limited human trials · first signs weeks 1-4

Evidence level

Limited human trials

60/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)


How it works

Palmitoyl-oligopeptide is a signal peptide coupled with a fatty acid (palmitic acid) that tells your skin cells to produce more collagen and elastin.

The fatty acid helps it penetrate the skin barrier, so it can reach deeper skin cells. This stimulates your skin's natural structural proteins, improving firmness, elasticity, and reducing signs of aging.

The deeper mechanism

Palmitoyl-oligopeptide is a palmitoyl-coupled signal peptide designed to improve skin penetration through increased lipophilicity while activating fibroblast-mediated collagen synthesis.

The palmitic acid moiety increases skin barrier penetration and cellular uptake, allowing the oligopeptide sequence to interact with cell surface receptors (potentially TGF-β-related signaling) or intracellular signaling pathways that upregulate type I and III collagen gene expression.

Palmitoyl conjugation is a biotechnological modification that mimics naturally occurring lipidated peptides, enhancing dermal bioavailability compared to hydrophilic parent sequences.

Signal peptide mechanisms activate fibroblast transcription factors (including NF-κB-dependent pathways) that increase ECM protein synthesis including hyaluronic acid production, improving hydration and dermal density.


What to expect

  1. Weeks 1-4

    What you might notice

    • Skin barrier strengthening and initial hydration improvements
    • Matrikine signaling activates fibroblast collagen and elastin gene expression
    • Subtle improvements in skin texture and moisture retention may be noticed

    What's normal

    • Full integration of Palmitoyl Oligopeptide into physiological systems is established
    • Long-term Palmitoyl Oligopeptide response remains personalized to your physiology
    • Palmitoyl Oligopeptide tolerance is well-maintained with consistent dosing

    What's next

    • Maintain your established Palmitoyl Oligopeptide protocol for sustained benefits
    • Continue periodic monitoring to confirm Palmitoyl Oligopeptide efficacy
    • Review comprehensive Palmitoyl Oligopeptide response with your provider
  2. Weeks 4-8

    What you might notice

    • Measurable firmness improvement begins
    • New collagen and elastin synthesis becomes apparent
    • Fine lines appear softer
    • Skin texture refinement progresses with continued twice-daily application

    What's normal

    • Palmitoyl Oligopeptide is now achieving steady-state pharmacokinetics
    • Measurable changes aligned with Palmitoyl Oligopeptide's mechanism may appear
    • Initial adjustment effects typically resolve by this point

    What's next

    • Maintain Palmitoyl Oligopeptide dosing exactly as established
    • Track progress toward intended outcomes in detail
    • Review lab work or biomarker changes with your healthcare team
  3. Weeks 8-12+

    What you might notice

    • Optimal results achieved
    • Significant wrinkle reduction documented in clinical studies
    • Improved elasticity, firmness, and overall skin tone
    • Continued use maintains and builds upon improvements

    What's normal

    • Full therapeutic effects of Palmitoyl Oligopeptide are well-characterized at this point
    • Maintenance of Palmitoyl Oligopeptide's therapeutic effects is typical
    • Tolerance patterns with Palmitoyl Oligopeptide are generally stable over months

    What's next

    • Comprehensive assessment of Palmitoyl Oligopeptide efficacy should be conducted
    • Discuss long-term continuation, cycling, or protocol modifications
    • Continue regular monitoring of relevant biomarkers or symptoms

Signs it's working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Palmitoyl Oligopeptide over time
  • Reduction in symptom frequency or severity

Signs it's working

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing results?

Common reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

How is Palmitoyl Oligopeptide different from Palmitoyl Pentapeptide-4 (Matrixyl)?

Palmitoyl Oligopeptide (Hexapeptide-12) uses a VGVAPG sequence derived from elastin, while Palmitoyl Pentapeptide-4 (Matrixyl) uses a KTTKS sequence derived from procollagen. Both are matrikine signal peptides but target slightly different aspects of ECM production. They are complementary and often found together in advanced formulations.

Can Palmitoyl Oligopeptide be used with retinol?

Yes. Palmitoyl Oligopeptide and retinol work through complementary mechanisms for collagen stimulation. Apply the peptide serum first, allow absorption, then apply retinol. For sensitive skin, consider using peptide in the morning and retinol at night.

How long until I see results?

Initial hydration improvements may be noticeable within 2-4 weeks. Measurable wrinkle reduction and firmness improvements typically require 8-12 weeks of consistent twice-daily application. Results continue to build with ongoing use.

Is Palmitoyl Oligopeptide safe for sensitive skin?

Yes. Palmitoyl Oligopeptide has an excellent safety profile with minimal irritation potential. It is well-tolerated across skin types including sensitive skin. The CIR (Cosmetic Ingredient Review) panel has affirmed its safety for cosmetic use.

What is the ideal concentration for best results?

Clinical evidence supports concentrations of 0.3-1% in finished products for meaningful anti-aging benefits. Higher concentrations (1-3%) may provide enhanced effects in intensive treatment formulations. Even very low concentrations (0.003%) show measurable biological activity in laboratory studies.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Palmitoyl Oligopeptide, on one page.

Palmitoyl Oligopeptide dosing protocol

Medical disclaimer

Palmitoyl Oligopeptide is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 11, 2026

0.002 % – 10 ppm Once or twice daily or several times daily · onset 1-2 weeks
Open the Palmitoyl Oligopeptide calculatorPalmitoyl Oligopeptide calculator